Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure
- 37 Downloads
A obesity paradox has been described following heart failure (HF). The aim of this study was to analyze the association between food intake-involved adipokines and long-term weight changes. Leptin, adiponectin, and omentin were analyzed in 92 acute HF (AHF) patients at discharge, classified on the basis of weight gains or losses > 6%. The mean follow-up was 256 ± 143 days. Leptin and adiponectin levels were similar among weight groups. However, omentin levels were higher in those patients who had gained weight (16 ± 5 ng/mL) than in those who had lost weight (12 ± 4 ng/mL) or showed no weight change (11 ± 5 ng/mL; p < 0.002). Omentin levels were the best independent predictors for patients with weight gain, who had less mortality and hospital readmission during the follow-up. The association between omentin levels and weight gain might explain part of the obesity paradox in HF.
KeywordsAcute heart failure Body weight changes Adipokines
We would like to thank patient’s participation. The present study was supported by Complejo Hospitalario Universitario de Santiago de Compostela (Santiago de Compostela, Spain), Fondo de Investigaciones Sanitarias (PIE13/00024), and (PI13/01852) from Plan Estatal de I + D + I 2013–2016 and cofounded by ISCIII-Subdirección General de Evaluación y Fomento de la Investigación el Fondo Europeo de Desarrollo Regional (FEDER).
Sources of Funding
Funding was provided by Fondo de Investigaciones Sanitarias (PIE13/00024) and (PI13/01852) from Plan Estatal de I + D + I 2013–2016.
Compliance with Ethical Standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 14.Fernandez-Trasancos, A., Agra, R. M., Garcia-Acuna, J. M., Fernandez, A. L., Gonzalez-Juanatey, J. R., & Eiras, S. (2017). Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells. Obesity (Silver Spring), 25, 1042–1049.CrossRefGoogle Scholar
- 18.Ponikowski, P., Voors, A. A., Anker, S. D., et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. European Heart Journal, 37, 2129–2200.CrossRefGoogle Scholar
- 19.Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Annals of Internal Medicine, 130, 461–470.CrossRefGoogle Scholar
- 24.Yancy, C. W., Jessup, M., Bozkurt, B., et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation, 128, 1810–1852.CrossRefGoogle Scholar
- 25.McMurray, J. J., Adamopoulos, S., Anker, S. D., et al. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. European Journal of Heart Failure, 14, 803–869.CrossRefGoogle Scholar